Pharmacometric Analysis
Pharmacokinetic Assays for Biologics | CellCarta
Clinical Pharmacology Regulatory Sciences in Drug Development and Precision Medicine: Current Status and Emerging Trends. - Abstract - Europe PMC
Database of pharmacokinetic time-series data and parameters for 144 environmental chemicals | Scientific Data
Data Reconciliation in EDC Platforms | Ask a CRO | PharPoint Research
Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle | PNAS
Phase I, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of GSK2879552 in Relapsed/Refractory SCLC - Journal of Thoracic Oncology
Pharmacometric Analysis
Pharmacokinetic and Statistical Considerations in First-in-Human Clinical Trials | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services
Regulus Therapeutics Announces Positive Topline Safety and Pharmacokinetic ( PK) Data from the Phase 1 Single-Ascending Dose (SAD) Clinical Trial of RGLS8429 for the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) -
Clinical Trial Phases
USA - FDA updates PK guidance for patients with impaired renal function - RIS.WORLD
Recommendations for the Design of Clinical Drug–Drug Interaction Studies With Itraconazole Using a Mechanistic Physiologically‐Based Pharmacokinetic Model - Chen - 2019 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases | Scientific Reports
Use of old antibiotics now and in the future from a pharmacokinetic/pharmacodynamic perspective - Clinical Microbiology and Infection
Use of pharmacokinetic/pharmacodynamic biomarkers to support rational cancer drug development | Biomarkers in Medicine
An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc):
A Fast Parameter Identification Framework for Personalized Pharmacokinetics | Scientific Reports
The utility of registry studies. AE: adverse event; PK:... | Download Scientific Diagram
